TIPRL, TOR signaling pathway regulator, 261726

N. diseases: 24; N. variants: 0
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0006826
Disease: Malignant Neoplasms
Malignant Neoplasms
0.020 Biomarker group BEFREE The positive correlation of TIPRL with LC3 and CD133 contributes to cancer aggressiveness: potential biomarkers for early liver cancer. 31727942 2019
CUI: C1306459
Disease: Primary malignant neoplasm
Primary malignant neoplasm
0.020 Biomarker group BEFREE The positive correlation of TIPRL with LC3 and CD133 contributes to cancer aggressiveness: potential biomarkers for early liver cancer. 31727942 2019
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.020 Biomarker disease BEFREE Furthermore, the statistical association and the diagnostic efficacies of TIPRL, LC3 and CD133 in HCC tissues were confirmed in a different IHC cohort. 31727942 2019
CUI: C0006826
Disease: Malignant Neoplasms
Malignant Neoplasms
0.020 Biomarker group BEFREE We expect TIP to be useful in a large number of emerging cancer immunity studies and development of effective immunotherapy biomarkers. 30154154 2018
CUI: C1306459
Disease: Primary malignant neoplasm
Primary malignant neoplasm
0.020 Biomarker group BEFREE We expect TIP to be useful in a large number of emerging cancer immunity studies and development of effective immunotherapy biomarkers. 30154154 2018
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.020 Biomarker disease BEFREE We investigated the role of human TIPRL protein in hepatocellular carcinoma (HCC). 22841785 2012
CUI: C0029882
Disease: Otitis Media
Otitis Media
0.010 Biomarker disease BEFREE Grading TIP is a valid method for accurate diagnosis of pediatric otitis media and can predict the tympanometry result with high statistical significance. 31202036 2019
CUI: C0039538
Disease: Teratoma
Teratoma
0.010 GeneticVariation disease BEFREE Our data suggest that approximately half of the patient with cisplatin-refractory or relapsed GCT salvaged with TIP or TICE chemotherapy and evidence of residual disease are at risk of harboring either viable GCT or teratoma. 30296502 2019
CUI: C0220620
Disease: Gastrointestinal Carcinoid Tumor
Gastrointestinal Carcinoid Tumor
0.010 GeneticVariation disease BEFREE Our data suggest that approximately half of the patient with cisplatin-refractory or relapsed GCT salvaged with TIP or TICE chemotherapy and evidence of residual disease are at risk of harboring either viable GCT or teratoma. 30296502 2019
CUI: C0220630
Disease: Adult Liver Carcinoma
Adult Liver Carcinoma
0.010 Biomarker disease BEFREE This data demonstrates that the complex involvement of TIPRL/LC3/CD133 in liver cancer aggressiveness can together or individually serve as potential biomarkers for the early detection of liver cancer. 31727942 2019
Liver and Intrahepatic Biliary Tract Carcinoma
0.010 Biomarker disease BEFREE This data demonstrates that the complex involvement of TIPRL/LC3/CD133 in liver cancer aggressiveness can together or individually serve as potential biomarkers for the early detection of liver cancer. 31727942 2019
CUI: C0345904
Disease: Malignant neoplasm of liver
Malignant neoplasm of liver
0.010 Biomarker disease BEFREE This data demonstrates that the complex involvement of TIPRL/LC3/CD133 in liver cancer aggressiveness can together or individually serve as potential biomarkers for the early detection of liver cancer. 31727942 2019
CUI: C0431399
Disease: Familial aplasia of the vermis
Familial aplasia of the vermis
0.010 Biomarker disease BEFREE We show that another Joubert syndrome-associated cilia tip protein, CSPP1, interacts with CEP104 at microtubules for the regulation of axoneme length. 31412255 2019
CUI: C0948908
Disease: Nephrotoxic serum nephritis
Nephrotoxic serum nephritis
0.010 Biomarker disease BEFREE The TNF-derived TIP peptide activates the epithelial sodium channel and ameliorates experimental nephrotoxic serum nephritis. 30905471 2019
CUI: C1368898
Disease: Adult Teratoma
Adult Teratoma
0.010 GeneticVariation disease BEFREE Our data suggest that approximately half of the patient with cisplatin-refractory or relapsed GCT salvaged with TIP or TICE chemotherapy and evidence of residual disease are at risk of harboring either viable GCT or teratoma. 30296502 2019
CUI: C2347762
Disease: Childhood Teratoma
Childhood Teratoma
0.010 GeneticVariation disease BEFREE Our data suggest that approximately half of the patient with cisplatin-refractory or relapsed GCT salvaged with TIP or TICE chemotherapy and evidence of residual disease are at risk of harboring either viable GCT or teratoma. 30296502 2019
CUI: C2827407
Disease: Infectious Otitis Media
Infectious Otitis Media
0.010 Biomarker disease BEFREE Grading TIP is a valid method for accurate diagnosis of pediatric otitis media and can predict the tympanometry result with high statistical significance. 31202036 2019
CUI: C0027627
Disease: Neoplasm Metastasis
Neoplasm Metastasis
0.010 Biomarker phenotype BEFREE The E3 Ubiquitin Ligase HectD1 Suppresses EMT and Metastasis by Targeting the +TIP ACF7 for Degradation. 29386124 2018
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.010 Biomarker group BEFREE We developed a user-friendly one-stop shop web tool called TIP to comprehensively resolve tumor immunophenotype. 30154154 2018
CUI: C0234233
Disease: Sore to touch
Sore to touch
0.010 Biomarker phenotype BEFREE The muscle TIP had superior values of subjective tenderness, juiciness, and slight off-flavor intensity when compared to all other muscles.The TIP and SUB were similar in WBSF. 28942340 2018
CUI: C0010674
Disease: Cystic Fibrosis
Cystic Fibrosis
0.010 Biomarker disease BEFREE Inhaled tobramycin, used to manage P. aeruginosa infection in CF patients, is available as powder (tobramycin inhalation powder, TIP) and solution (tobramycin inhalation solution, TIS). 28643178 2017
CUI: C1269955
Disease: Tumor Cell Invasion
Tumor Cell Invasion
0.010 Biomarker phenotype BEFREE ExPEC harboring a deletion of the gene encoding the mannose-binding type 1 pilus tip protein FimH demonstrated reduced binding and invasion compared to strains lacking known <i>E. coli</i> virulence factors. 28808163 2017
CUI: C0476089
Disease: Endometrial Carcinoma
Endometrial Carcinoma
0.010 PosttranslationalModification disease BEFREE TIPRL1 silencing restored GSK3β phosphorylation and rescued the EC cell growth advantage. 27485451 2016
CUI: C1458155
Disease: Mammary Neoplasms
Mammary Neoplasms
0.010 AlteredExpression group BEFREE Microtubule plus‑end‑binding protein (+TIP) EB1 has been shown to be upregulated in breast cancer cells and promote breast tumor growth in vivo. 25310526 2015
CUI: C1512409
Disease: Hepatocarcinogenesis
Hepatocarcinogenesis
0.010 AlteredExpression disease BEFREE The TOR signaling pathway regulator-like (TIPRL) protein, the mammalian ortholog of yeast TIP41, was identified in an expression profiling screen for factors that regulate human liver carcinogenesis. 22841785 2012